KemPharm
KMPH
$5.81
Share price
-0.34%
Change (1 day)
6.61%
Change (1 year)
Categories
KemPharm (KMPH) - Total debt
Total debt on the balance sheet as of December 2022 : $23.11 M
According to KemPharm's latest financial reports the company's total debt is $23.11 M. A company’s total debt is the sum of all current and non-current debts.
KemPharm - Total debt on balance sheet (from 2014 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $23.11 M | 1336.73% |
| 2021-12-31 | $1.6 M | -97.72% |
| 2020-12-31 | $70.54 M | -11.29% |
| 2019-12-31 | $79.52 M | -3.07% |
| 2018-12-31 | $82.04 M | -12.23% |
| 2017-12-31 | $93.48 M | 2.36% |
| 2016-12-31 | $91.32 M | 295.37% |
| 2015-12-31 | $23.09 M | 27.29% |
| 2014-12-31 | $18.14 M | 357.08% |
| 2013-12-31 | $3.97 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Theravance Biopharma
TBPH | $49.15 M | 112.65% | Cayman Islands |
 Jazz Pharmaceuticals JAZZ | $5.78 B | 24,924.87% | 🇮🇪 Ireland |
 ANI Pharmaceuticals ANIP | $0.28 B | 1,135.75% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $2.17 M | -90.60% | 🇺🇸 USA |